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Abstract
The liver has a high regenerative capacity after acute liver injury, but this is often
impaired during chronic liver injury. The existence of a dedicated liver stem cell
population that acts as a source of regeneration during chronic liver injury has
been controversial. Recent advances in transgenic models and cellular
reprogramming have provided new insights into the plasticity of the liver
epithelium and directions for the development of future therapies. This article
will highlight recent findings about the cellular source of regeneration during
liver injury and the advances in promoting liver regeneration.
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Core tip: There have been controversies regarding the existence of a true liver stem cell
population. Nevertheless, more evidence is beginning to reveal that cellular plasticity in
the liver plays a role in liver regeneration. This mini-review highlights recent findings
about plasticity in the liver epithelium.
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INTRODUCTION
The liver is the largest internal organ in humans, and has exceptional regenerating
capacity. The liver epithelium mainly consists of hepatocytes and cholangiocytes, with
70%-85%  of  the  liver  consisting  of  hepatocytes.  Hepatocytes  function  in  drug
metabolism,  protein  synthesis  and  bile  secretion.  The  biliary  tree  is  a  three-
dimensional branching structure lined by cholangiocytes to form tubular networks.
These networks transport bile for storage in the gall bladder, or to the duodenum for
the breakdown of fats. The liver is relatively quiescent compared to other epithelial
organs such as the skin and intestines, with minimal hepatocyte proliferation during
homeostasis[1,2]. The average lifespan of a hepatocyte ranges from 200-400 d[3]. It is
believed that the liver has a ‘’two-tiered’’ regeneration system, where hepatocytes
proliferate and regenerate the liver upon acute liver damage, and the liver progenitors
or oval cells orchestrate the regeneration process during chronic liver injury when
hepatocyte  proliferation  is  impaired[4].  Recent  advances  in  lineage-tracing  and
imaging techniques have provided new perspectives in addition to the original ‘’two-
tiered’’ idea. This review will focus on recent advances in stem cell biology and tissue
repair to highlight the plasticity of the liver epithelium during regeneration.
REGENERATIVE POTENTIAL OF CHOLANGIOCYTES
The existence and the regenerative potential of hepatic progenitor cells (HPCs) or oval
cells have been debatable. HPCs are a subpopulation of cells in the liver characterised
by  their  oval  shape  and  high  nucleus  to  cytoplasm  ratio  when  hepatocyte
proliferation is inhibited[5]. Expansion of HPCs was observed in rat models of chronic
liver injury in which hepatocyte proliferation is inhibited by the administration of 2-
acetylaminofluorene (2-AAF). This was also observed upon hepatic injury such as
carbon tetrachloride (CCl4) or partial hepatectomy (PHH)[6,7]. In addition to rat studies,
HPC  activation  was  also  observed  in  mouse  studies  and  human  chronic  liver
disease[8-11]. In particular, the presence and contribution of a facultative liver stem cell
population in human liver regeneration are highlighted by studies showing shared
mitochondrial  DNA  mutations  between  HPC  and  the  regenerative  nodules  in
cirrhotic patients, suggesting their common origin[12,13].
HPC activation is a part of the dynamic change of the liver in response to chronic
liver injury called ductular reaction (DR). Besides HPC activation, DR also includes
immune cell infiltration, remodelling of the extracellular matrix, and myofibroblast
activation[10,14,15].  Label-retaining  assays  that  determine  the  cycling  speed  of  the
ductular cell populations have suggested multiple potential niches for slower cycling
ductular cells after injury. These include the intralobular bile ducts, areas around
periductal mononuclear cells, peribiliary hepatocytes, and the Canal of Hering[16].
However, most studies that characterised DR relied on immunohistochemistry of
paraffin-embedded sections, which has the limitation of being two-dimensional and
lacking spatial information. This leads to the confusion that the DR observed is the
activation of endogenous liver stem cells that leave their stem cell niche, migrate
towards the site of injury and differentiate into hepatocytes. However, an elegant
study performed by Kamimoto and colleagues  used three-dimensional  imaging
techniques to demonstrate that  instead of  leaving their  niche and migrating,  the
biliary  tree  undergoes  complex  remodelling  without  diverging  from  the  main
structure[17,18]. Furthermore, they also observed that cholangiocytes do not proliferate
uniformly,  which  fits  with  the  previous  label-retaining  studies  suggesting
heterogeneity  in  the  proliferative  capacity  of  cholangiocyte  populations.  These
indicate the presence of HPC populations within the biliary epithelium with different
regenerative potentials. However, the identity of HPCs within cholangiocytes remains
elusive,  as  there  are  no  specific  markers  to  differentiate  HPCs  from
cholangiocytes[19,20].  Nevertheless,  subpopulations  of  cholangiocytes  have  been
identified with markers such as Leucine-rich repeat-containing G-protein coupled
receptor 5 (LGR5), ST14, Trop2, neural cell adhesion molecule (NCAM), MIC-1C3,
CD133, etc[21-26].
Advances in transgenic mice and gene editing technologies in the past decades
have facilitated lineage-tracing studies of cholangiocytes in the background of chronic
liver  injury,  which is  mainly induced by the administration of  special  diets.  For
example,  the  choline-deficient,  ethionine-supplemented  (CDE)  diet  and  the
methionine  choline-deficient  (MCD)  diet  can  induce  hepatocellular  injury[8,27].
Alternatively,  cholestatic  injury  can  be  induced  by  the  administration  of  a  3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet[28]. Lineage-tracing studies using
the Cre-lox system and traceable proteins such as GFP, RFP and B-galactosidase
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facilitate the identification of the origin and regenerative potential of cholangiocytes
during homeostasis, chronic liver injury and post-recovery. However, lineage-tracing
studies performed by multiple groups showed mixed results about the regenerative
potential of cholangiocytes[24,29-31]. Rodrigo-Torres et al[29] and Espanol-Suner et al[30]
used a tamoxifen-inducible Cre system controlled under the Hepatocyte Nuclear
Factor  1B  (HNF1B)  and  Osteopontin  (OPN)  promoters,  respectively,  to  label
cholangiocytes  during  homeostasis.  They  both  showed  that  cholangiocytes  can
differentiate  into  hepatocytes  following  chronic  liver  injury.  However,  the
contribution of  biliary cells  towards hepatocytes are minimal in these studies (<
3%)[29,30].  On the  contrary,  when Cre  is  controlled  under  the  transcription factor
Forkhead box L1 (Foxl1) promoter, the degree of cholangiocyte-derived hepatocytes
increases up to 29%, and ablation of the Foxl1 population results in impaired DR and
liver regeneration[32-34]. The higher contribution from the Foxl1 population compared
to the Hnf1b and the Opn population might be due to the former study’s use of a
constitutive Cre system, and the latter study’s use of an inducible Cre system, in
which the cell-labelling efficiency can be limited due to variable Cre penetrance. In
contrast, the constitutive Cre system will always have the caveat that any cells that
transiently expressed the promoter gene will be labelled, causing less accurate results.
It  is  also worth noting that  several  studies  do not  show direct  differentiation of
cholangiocytes into hepatocytes following liver injury, which will be discussed in the
sections below (Figure 1).
The existence of HPCs remains controversial,  largely due to the mixed results
obtained from different lineage-tracing studies[31,35,36]. Technical factors such as the
selection of the promoter that controls the expression of Cre recombinase is one of the
causes for this discrepancy. For example, it has been shown that some hepatocytes
express Sox9 after tamoxifen injection or liver injury, which may result in the labelling
of hepatocytes, potentially leading to the erroneous conclusion that overestimates the
contribution  from  cells  with  biliary  origin[35,37-39].  Furthermore,  it  is  known  that
hepatocytes have a propensity to express certain biliary markers like osteopontin
upon stress[40]. It seems that biliary markers such as Krt19 are an exception to this
phenomenon, as Krt19 is not expressed by hepatocytes following injury, making it
one of  the most  common markers  used for  lineage-tracing studies[39].  It  is  worth
investigating whether other biliary markers such as EpCAM or Trop2 share similar
characteristics  to  Krt19  during  liver  injury[25].  Another  potential  reason  for  the
discrepancy might be the variable in injury models applied. For example, different
studies have used different percentages of ethionine in water (0.1%-0.15%)[33,35]. The
level of ethionine controls the severity of injury by inhibiting hepatocyte proliferation,
which  is  crucial  for  the  activation  and  differentiation  of  cholangiocytes  into
hepatocytes. The level of injury can also be affected by age, gender, the intake of
ethionine-supplemented water and special  diets.  As the intake of  diets  is  highly
variable across individual mice, this might lead to the discrepancy observed due to
the high regenerative capacity of hepatocytes. A recent study performed by Deng et
al[41] showed that Krt19-positive cells can differentiate into hepatocytes following long-
term liver injury induced by the DDC diet. This shows the importance of selecting an
appropriate  injury  model  to  investigate  the  true  regenerative  potential  of
cholangiocytes.
In comparison to dietary models, lineage-tracing studies involving liver injury
induced by transgenic approaches appears to result in a more robust contribution of
hepatocytes  from non-hepatocyte  sources[42,43].  Transgenic  approaches  to  induce
hepatocyte senescence through the deletion of Mdm2, a negative regulator of p53, has
been developed to simulate human chronic liver disease. In this system, where the
inducible Ah-Cre is controlled by the Cyp1a promoter, hepatocytes can be targeted by
the administration of B-Naphthoflavone to trigger a senescence phenotype, hence
causing a robust DR and the regeneration of the liver parenchyma contributed by a
non-hepatocyte  source[42,44].  Besides  inducing  cellular  senescence,  hepatocyte
proliferation can also be disrupted by the deletion of the ItgB1 gene[45]. Hepatocytes
that  have  defective  ItgB1  have  impaired  proliferation  due  to  disrupted  HGF
signalling[45].  Overexpression of p21, a cyclin-dependent kinase inhibitor, has also
been used to impair hepatocyte proliferation through the delivery of AAV8 vector
packaged  with  the  p21  codon[43].  When  combining  the  inhibition  of  hepatocyte
proliferation (Itgb1 knockout or AAV8-p21 delivery) with dietary-induced chronic
liver injury, biliary cells can commit to both biliary and hepatocyte fates[43]. Although
the contribution of cholangiocytes into hepatocytes does not lead to full repopulation,
it  is  still  a  significant  contribution  (25%)  compared  with  previous  models.
Furthermore, suppression of the Wnt/β-catenin pathway in hepatocytes promotes the
differentiation of cholangiocytes into hepatocytes[46].  However, it remains unclear
whether full repopulation of the liver from cholangiocytes can be achieved. The loss
of ItgB1, the Wnt pathway or p21 overexpression in all hepatocytes do not completely
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Figure 1
Figure 1  Schematic summarising potential non-hepatocyte sources of regeneration. Lineage-tracing models using Cre recombinase controlled under a
cholangiocyte-specific promoter have shown cholangiocytes giving rise to hepatocytes. Alternatively, Sox9+ hybrid hepatocytes have been shown to give rise to both
cholangiocytes and hepatocytes.
resemble the mechanisms of human liver disease. Nevertheless, the impairment of
hepatocyte regenerative capacity promotes the differentiation of cholangiocytes as a
proof-of-principle to demonstrate the regenerative capacity of cholangiocytes. Despite
this, the complex regulatory process that triggers cholangiocytes to differentiate into
hepatocytes remains to be identified. It was recently reported that Histone deacetylase
1 (HDAC1) regulates the commitment of  cholangiocytes to biliary epithelial  and
hepatocyte fates through controlling Sox9 expression in zebrafish and mouse. This
reveals  extra  molecular  pathways  that  work in  conjunction with  the  previously
identified Wnt and Notch pathways in regulating liver regeneration[14,47]. Nevertheless,
it  remains to be tested whether promoting endogenous regeneration through the
activation and differentiation of biliary cells to repopulate the liver parenchyma is
plausible.
Besides the advances achieved in lineage-tracing studies, the development of the
organoid culture system pioneered by the Clevers group revolutionised the field of
regenerative medicine. First established in 2009 by Sato et al[48], organoid culture was
used to culture intestinal stem cells that express the Wnt target gene leucine-rich-
repeat-containing G protein-coupled receptor 5 (Lgr5).  This technology was then
applied by the same group to the liver to form liver organoids, and is now widely
used by researchers for in vitro modelling, drug screening and gene sequencing[24,49,50].
Endogenous lineage-tracing of Lgr5-expressing cells using the Lgr5-IRES-creERT2
reporter mice showed that Lgr5-expressing cells can contribute to both cholangiocytes
and hepatocytes after liver damage[24]. Interestingly, Lgr5 expression is not detected in
healthy liver, but only detected in cholangiocytes after injury. This indicates that Lgr5
is  transiently  expressed in  a  subpopulation  of  cholangiocytes  that  activate  Wnt
signalling and repopulate the liver when required. However, the origin and identity
of this  trans-amplifying population in the liver during quiescence remains to be
investigated. Identifying the origin of the Lgr5 population will reveal whether either
there  are  predetermined  residential  liver  stem  cells,  or  cholangiocytes  obtain
regenerative capacity stochastically and regenerate the liver parenchyma during
injury. Although the controversy regarding the existence of a dedicated liver stem cell
population  remains,  subpopulations  of  cholangiocytes  have  been  identified.
Furthermore, it appears that the cells of the liver epithelium (i.e. cholangiocytes and
hepatocytes)  can  obtain  cellular  plasticity  and  differentiate  into  the  other
compartment when one compartment is significantly damaged.
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EXOGENOUS REPOPULATING CAPACITY OF
CHOLANGIOCYTES
In  contrast  to  lineage-tracing  studies,  there  are  more  convincing  results  in
transplanting isolated or in vitro-cultured cholangiocytes[42,51-53]. Transplantation assays
have been widely used by the liver research community to prove the repopulating
capacity of different cell populations. As the most effective treatment for liver disease
is whole organ transplantation, it is common to seek alternatives using cells isolated
from the liver to overcome the challenges faced in allogenic transplantations. Most
transplantation assays are designed in a way that selective advantages are provided to
the  donor  population,  and this  is  often  achieved by  causing  defects  to  the  host
hepatocytes. The most widely used models are the fumarylacetoacetate hydrolasemice
(Fah)-deficient and the urokinase-type plasminogen activator-overexpressing (uPA)
mice[54,55].
The Fah-deficient mice lack the functional fumarylacetoacetate hydrolase (Fah), a
metabolic enzyme required for the last step of the tyrosine catabolism pathway. Fah
mice develop liver diseases and die within 12 hours after birth from hypoglycaemia[54].
This defect can be corrected by blocking the accumulation of hepatotoxins through the
administration of 2-(2-nitro-4-trifluoro-methylbenzyol)-1,3-cyclohexanedione (NTBC)
to  partially  recover  liver  function[56].  The  administration  of  NTBC prolongs  the
lifespan of Fah mice and enables this strain to be suitable for liver repopulation[57]. On
the other hand, the uPA transgenic mice have the mouse urokinase-type plasminogen
activator (uPA) gene under the control of the mouse albumin enhancer/promotor.
Hepatocyte-specific expression of uPA causes liver toxicity and chronic liver injury,
hence creating a selective advantage for transplanted hepatocytes[55,58]. However, the
limitations of this model are the narrow time transplantation window after birth and
the poor breeding efficiency of this strain. In addition, only homozygous animals are
good recipients for liver cell  transplantation[59].  Immunocompromised variants of
these strains have also been developed,  and transplantation of  human or rodent
hepatocytes  has  shown  promising  repopulation  capacity  after  xenotransplan-
tation[60-62].
With hepatocyte transplantation as the gold-standard for the liver-repopulating
transplantation  assay,  the  liver-repopulating  capacity  of  isolated  HPCs  were
investigated  using  similar  assays.  HPCs  can  be  enriched  by  density  gradient
centrifugation from the liver non-parenchymal fraction after protease digestion[21,25,53].
Fluorescence-activated  cell  sorting  (FACS)  is  often  used  to  isolate  a  pure  HPC
population. However, HPCs do not have a specific marker and often share surface
markers (e.g., c-kit, Thy-1) with other cell types such as haematopoietic cells[6,63,64]. This
raised  doubts  about  whether  HPCs  originate  from  the  bone  marrow,  but
transplantation assays and lineage-tracing studies have proven that HPCs originate
from cholangiocytes and not the bone marrow[42,53]. Multiple surface markers have
been used to isolate cholangiocyte subpopulations with liver-repopulating capacity,
which include EpCAM, Trop2, CD24, CD133, LGR5, c-kit, CD44, Thy-1, etc[22,25,42,51,53,57].
Due to the relatively low numbers of isolated cells, most studies culture the isolated
cells in vitro before transplantation. Upon transplantation, cells can differentiate into
hepatocytes and self-renew[21,22,24,25,42,51,53,63]. However, the magnitude of repopulation is
still relatively low compared to primary hepatocyte transplantation, which remains a
challenge for using HPCs in cell therapy[65].  Refinements to increase the degree of
repopulation, either by targeting the engraftment efficiency or the differentiation
capacity, are required. Nevertheless, an advantage of using biliary-derived cells for
transplantation is that cholangiocytes are more resistant to protease digestion than
hepatocytes and can be cultured in vitro,  which is difficult to achieve for primary
hepatocytes.  In  addition  to  regenerating  damaged  hepatocytes,  human  liver
organoids derived from cholangiocytes have also been used to regenerate extrabiliary
bile  ducts  in  vivo  after  being seeded with biodegradable  scaffolds[66].  The use  of
cultured cholangiocytes to regenerate damaged liver epithelium seems promising.
However,  the  heterogeneity  of  cells  within  the  culture,  and whether  prolonged
culture alters the characteristics and the long-term stability of the cells, need to be
further investigated.
THE PLASTICITY OF HEPATOCYTES
The  liver  is  deemed a  highly  regenerative  organ  mainly  due  to  the  remarkable
regenerative capacity of hepatocytes. The proliferative capacity of hepatocytes is well
characterised such that when acute liver injury occurs, hepatocytes initiate a series of
pathways to restore the lost mass[67]. These studies are mostly performed using the
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PHH model, where a substantial portion of the liver is resected. It was commonly
presumed  that  proliferation  is  the  main  mechanism  used  by  hepatocytes  to
compensate for the loss of liver mass. However, a study by Miyaoka and colleagues
show that  hepatocyte  hypertrophy  (i.e.  increase  in  hepatocyte  size)  contributes
concurrently with proliferation to compensate for the loss of liver mass[68,69]. However,
this regeneration process does not promote regrowth of the original resected lobes,
but instead, the replacement of the original mass occurs at the remnant lobes. It has
been  showed  that  YAP/Hippo  signalling  plays  a  major  role  in  controlling  the
restoration of the liver mass to its original size[70]. However, it needs to be noted that
in  the  PHH  model,  the  remnant  lobes  are  not  affected  by  any  injury,  which  is
uncommon in most clinical  cases of  acute liver failure.  Patients have substantial
inflammatory effects or senescence in the liver, such as paracetamol overdose.
The use of the Adeno-associated Virus (AAV) vector, a small (approximately 5 kb
long), non-enveloped virus for transgene delivery specifically into hepatocytes, allows
researchers to lineage-trace hepatocytes during homeostasis and injury[71]. Gao et al[72]
isolated  AAV serotype  8  (AAV8),  which  has  a  10-100-fold  higher  liver  tropism
compared  to  other  AAV  serotypes.  Malato  et  al [71]  used  the  hepatotropism
characteristic  of  the  AAV8  to  introduce  Cre  recombinase  controlled  under  the
hepatocyte-specific transthyretin (Ttr) promoter to target hepatocytes, which has a
higher specificity than the widely used Alb-Cre. They lineage-traced the labelled
hepatocytes under the context of homeostasis, acute liver injury, and biliary injury.
During  homeostasis  and acute  liver  injury,  they  did  not  find any evidence  that
hepatocytes are derived from the biliary compartment. However, they observed a
small amount of biliary-derived, periportal hepatocytes following bile duct ligation
and DDC injury, suggesting a population within the cholangiocyte population that
can differentiate into hepatocytes following injury. However, this conclusion is based
on the authors’ observation of unlabelled hepatocytes located at the periportal region,
instead of positively lineage-traced biliary cells.  The same group went further to
investigate  whether  cholangiocytes  can  differentiate  into  hepatocytes  following
chronic  liver  injury  using  the  CDE diet  regime,  which  predominantly  damages
hepatocytes[36].  Surprisingly, in contrast to the DDC model,  the authors observed
minimal (less than 1%) production of hepatocytes by cholangiocytes after chronic liver
injury. This was further confirmed with a positive lineage-tracing model using CK19-
CreER;R26R-RFP mice. Furthermore, the authors also showed that mesenchymal cells
cannot differentiate into hepatocytes after chronic liver injury. Yanger et al[31] further
investigated the source of newly formed hepatocytes following chronic liver injury
using CK19-CreER; R26R-YFP mice by applying different types of injury, including
DDC, CDE and CCl4  administration, as well as an alpha-naphthyl-isothiocyanate
(ANIT)  diet.  Similar  to  what  Schaub  et  al[36]  observed,  they  did  not  detect  any
production of hepatocytes from YFP-labelled biliary cells after injury, regardless of
the timing of  cell  labelling before or during injury.  These suggest  that  quiescent
cholangiocytes or activated atypical duct cells cannot differentiate into hepatocytes
following injury. They further characterised the source of regenerating hepatocytes
following  liver  injury  using  an  AAV8 vector  packaged with  a  Cre  recombinase
controlled under a hepatocyte-specific Thyroid Binding Globulin promoter (AAV8-
TBG-Cre). Hepatocytes from R26R-YFP mice are labelled with YFP after AAV8-TBG-
Cre  administration.  They  observed no  reduction  in  the  amount  of  YFP-labelled
hepatocytes following treatment with the panel of injury models mentioned above,
including the widely used CDE and DDC. This suggested that the newly formed
hepatocytes derived from self-duplication of pre-existing hepatocytes rather than
from other cell populations[31].
These observations require further follow-up investigation as to whether there is a
population of hepatocytes that possess a higher regenerative capacity[31,35,36,71]. Wang et
al[73]  reported that  a  population  of  pericentral  hepatocytes  that  express  the  Wnt
responsive gene Axin2  migrate towards the periportal region during homeostasis.
This  Axin2+  population  also  expresses  the  hepatoblast  marker  Tbx3,  and
differentiates into Tbx3-negative hepatocytes. Furthermore, the Axin2+ population
proliferates faster, is mostly diploid and its Axin2 expression is dependent on the Wnt
signals  provided  by  the  endothelium  at  the  central  vein.  This  reawakened  the
streaming liver hypothesis proposed by Zajicek et al[74] 30 years ago, which claims that
hepatocytes from the portal region gradually advance towards the central region
during homeostasis.  In this  study,  however,  the stream starts  from the opposite
direction instead (Figure 2). However, recent studies showed that despite the presence
of  Wnt  activity  in  the  pericentral  hepatocytes,  this  population does  not  possess
proliferative advantages over other hepatocyte populations during homeostasis and
acute injury[75]. Instead, proliferation rates across the three acinar zones are similar,
and  regeneration  is  performed  by  hepatocytes  with  high  levels  of  telomerase
expression[76].
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Figure 2
Figure 2  Schematic summarising the regenerative potential of hepatocytes.In vivo, periportal and pericentral hepatocytes regenerate the liver with different
regenerative mechanisms. In vitro, hepatocytes can be converted into liver progenitors with extrinsic factors.
Another report by Font-Burgada et al[77] suggests that a population of hepatocytes
named hybrid  hepatocytes  (HybHP)  resides  close  to  the  biliary  epithelium and
expresses  Sox9  during  homeostasis.  In  both  chronic  liver  injury  models  of  CCl4
administration as well as the MUP-uPA transgenic model, HybHP repopulate the
damaged population and manage to differentiate into zone 3 hepatocytes with the
expression of glutamine synthetase. Interestingly, under the CDE diet regime, they
found that most HybHP were killed, but no contribution of hepatocytes from the
biliary cells was observed albeit the existence of extensive DR. Furthermore, they
found HybHP can transdifferentiate into biliary-like cells that express biliary markers
like Sox9, Opn, and Ck19 when induced with cholestatic injury from a DDC diet.
Transcriptional analysis revealed the hybrid character of HybHP, as this population
expresses a cluster but not all of genes that are usually expressed by cholangiocytes.
However, it remains to be investigated whether this population can fully differentiate
into mature cholangiocytes, and this might explain the differences in the observations
made by Malato et al[71] and Yanger et al about whether hepatocytes can differentiate
into cholangiocytes after injury. Upon transplantation into the immunodeficient Fah-
/-Rag2-/-Il2rg-/- transgenic model, HybHP exhibit higher repopulation capacity than
conventional hepatocytes or HPC. Despite their regenerative capacity, neither HybHP
nor HPC preferentially  give rise  to  hepatocellular  carcinoma (HCC),  suggesting
tumorigenesis is  a random event that occurs equally in all  cell  types rather than
preferentially in certain cell populations. In addition, the HybHP phenotype was also
observed by Tarlow et al[78] after chronic liver injury, in which hepatocytes can obtain a
biliary phenotype with the expression of the cholangiocyte marker MIC-1C3 (hepPD).
Although they share similar surface marker expression, the transcriptional profile of
hepatocytes and biliary-derived MIC-1C3-expressing cells are different, and these two
populations behave differently in vitro, with the former maintaining a more hepatic-
like  profile.  These  Sox9-expressing  hepPD cells  can  also  differentiate  back  into
hepatocytes after injury[78]. Both the Tarlow and Font-Burgada studies demonstrated
the plasticity of hepatocytes after injury, and the heterogeneity of hepatocytes within
the liver does not only restrict to their zonation and drug metabolic functions, but also
occurs in the context of their regenerative potential. Interestingly, the conversion of
hepatocytes into biliary-like cells was observed in the DDC model but not in the
Thioacetamide (TAA) model[18]. This might due to the pathophysiology caused by
different injury models, in which the DDC is a model for cholestatic liver injury whilst
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the TAA model is a hepatotoxic injury model. This highlights the plasticity in the liver
when cholestatic  injury  occurs,  and that  hepatocytes  can  transdifferentiate  into
biliary-like cells due to damage in the biliary compartment. On the other hand, when
hepatocyte  proliferation  is  impaired,  cholangiocytes  can  differentiate  into
hepatocytes.
The plasticity of hepatocytes after chronic liver injury is also recapitulated in vitro
by the conversion of mature hepatocytes in mice and rats into progenitor-like cells
using a cocktail of small molecules that consists of ROCK-inhibitor(Y-27632), TGF-β
inhibitor  (A-83-01)  and Wnt  agonist  (CHIR99021)[79]  (Figure  2).  The  chemically-
induced liver progenitors (CLiPs) can be cultured long-term, as well as differentiate
into  hepatocytes  and  biliary  cells  in  vitro  and  in  vivo  after  transplantation.  The
development of CLiPs has overcome the limitation that primary hepatocytes could
not  maintained be in  prolonged culture  in  vitro,  and the low cell  number of  the
regenerative progenitor cells in vivo. This opens a new possibility of using CLiPs for
cell therapy. Whether all hepatocytes or only a subpopulation can be reprogrammed
into CLiPs, and the applicability of using human hepatocytes for CLiPs generation,
remains to be investigated in order to translate this into future therapy.
CELLULAR REPROGRAMMING FOR LIVER REGENERATION
The 2006 discovery of induced pluripotent stem cells (iPSCs) by the expression of
Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) in fibroblasts sparked broad interest in
cellular reprogramming[80]. Hepatocyte-like cells have been generated from embryonic
stem cells (ESCs) and iPSCs using multistep protocols in vitro[81-83]. When co-cultured
with  other  cell  types  such  as  mesenchymal  and  endothelial  cells,  iPSC-derived
hepatocytes  can  form three-dimensional  ‘’liver  buds’’.  The  liver  buds  can  form
vascular networks with the host vasculature after cranial transplantation[84]. These
cells  are  potentially  promising  for  drug  screening,  disease  modelling,  and  cell
replacement therapy. However, ethical issues, efficacy and long-term stability of these
cells in vivo  remains a challenge to translate these into therapy[85,86].  Besides using
ESC/iPSC-derived  hepatocytes,  researchers  also  considered  the  possibility  of
bypassing  the  reprogramming  into  pluripotency  by  shortening  the  multistep
reprogramming  protocol,  or  even  directly  converting  adult  somatic  cells  into
functional hepatocytes[87,88]. The overexpression of two transcription factors including
Hnf4a  with  the  combination  of  either  Foxa1,  Foxa2,  or  Foxa3  can  induce
reprogramming in  vitro  of  cultured mouse embryonic  and adult  fibroblasts  into
hepatocyte-like (iHep) cells.  These cells  maintained hepatic function in vitro  and
contribute to the regeneration of the liver parenchyma after transplantation[88]. Direct
reprogramming of hepatic myofibroblasts into hepatocytes in vivo with adenovirus
has also shown decreased fibrosis in mice[89]. Advances in cellular reprogramming
have opened a new area of regenerative medicine. However, the efficiency, epigenetic
memory and stability of transdifferentiated hepatocytes remains a challenge for the
therapeutic use of cells generated by genetic reprogramming.
CONCLUSION AND FUTURE DIRECTIONS
A lot has been learned about liver plasticity in recent years, especially regarding
hepatocytes. It appears that cellular plasticity in the liver is bidirectional and injury-
dependent,  where hepatocytes are able to transdifferentiate into biliary-like cells
under certain conditions. However, when the proliferative capacity of hepatocytes is
impaired, cholangiocytes become the facultative liver stem cells that differentiate into
hepatocytes.  It  remains to  be investigated whether  compartmentalised stem cell
populations exist within the liver as in other epithelial organs, or if the acquisition of
stem cell properties by cholangiocytes is a stochastic event[90,91]. Nevertheless, it seems
that the plasticity of hepatocytes and cholangiocytes reflects what has been observed
in other organs such as the skin and intestines, where residential stem cells acquire
plasticity and differentiate after injury[90,92]. Future studies involving next generation
sequencing at  the single-cell  level  will  provide us with new perspectives on cell
identity  and  the  involvement  of  epigenetic  alterations  during  regeneration.
Advancements in our understanding of tissue repair, cellular reprogramming and
bioengineering will be beneficial for developing models for drug screening, and may
even translate into cell therapy. Modulation of the regenerative niche will hopefully
enhance the endogenous regenerative capacity of the liver (Figure 3).
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Figure 3
Figure 3  Schematic showing the importance of understanding tissue repair and stem cell biology, and their contributions to developing future therapies to
promote liver regeneration. Studies focusing on understanding the mechanisms of tissue repair have suggested that cell populations with high cellular plasticity
include both cells of the biliary tree and hepatocytes. The fields of stem cell biology and regenerative medicine have used signals and key factors required during
embryonic development to produce hepatocyte-like cells derived from either adult or embryonic sources. In conjunction, these will advance the liver regeneration field.
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